Medscape7d
Technology Insight: ECP for the treatment of GvHD-Can We Offer Selective Immune Control Without Generalized Immunosuppression?
Cite this: Technology Insight: ECP for the treatment of GvHD-Can We Offer Selective Immune Control Without Generalized Immunosuppression? - Medscape - Jun 01, 2006. SR Marshall is a ...
Medical News Today17d
What are the treatment options for graft-versus-host disease (GVHD)?
Sirolimus is an mTOR inhibitor that healthcare professionals occasionally use alongside steroid therapy in GVHD. ECP uses ultraviolet light to alter the function of white blood cells called ...
pharmaphorum7mon
Incyte builds GvHD presence with Niktimvo approval
The FDA has approved Incyte's axatilimab as a treatment for chronic graft-versus-host disease (GvHD), making it a companion to the company's Jakafi for the disorder. The US regulator has cleared ...
pharmaphorum7mon
Mallinckrodt sells Therakos unit on at a discount
including cutaneous T-cell lymphoma (CTCL), and to treat transplant rejection and graft-versus-host disease (GvHD). ECP involves taking a patient's blood and then isolating and treating abnormal ...
Nature13y
Use of immunoglobulins in the prevention of GvHD in a xenogeneic NOD/SCID/γc− mouse model
The efficacy of IVIG in preventing GvHD has not been definitely demonstrated clinically. Using a xenogeneic model of GvHD in NOD/SCID/γc− (NSG) mice, we showed that weekly administration of ...
Medscape10d
Technology Insight: ECP for the treatment of GvHD-Can We Offer Selective Immune Control Without Generalized Immunosuppression?
Cite this: Technology Insight: ECP for the treatment of GvHD-Can We Offer Selective Immune Control Without Generalized Immunosuppression? - Medscape - Jun 01, 2006. SR Marshall is a ...